Evidence map›Paper›PMID 22287577›Full record

ArticleCardiovascular research2012

VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.

Revu Ann Alexander, Gerald W Prager, Judit Mihaly-Bison, Pavel Uhrin, Stefan Sunzenauer, Bernd R Binder, Gerhard J Schütz, Michael Freissmuth, Johannes M Breuss

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Automated High-Throughput Live Cell Monitoring of Scratch Wound Closure.Biomedical engineering and computational biology · 2024
    Article
  6. Endothelial-specific Enhancer as a Cis Element ofCurrent pharmaceutical design · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Revu Ann AlexanderInstitute of Vascular Biology and Thrombosis Research, Vienna A-1090, Austria.
Gerald W Prager
Judit Mihaly-Bison
Pavel Uhrin
Stefan Sunzenauer
Bernd R Binder
Gerhard J Schütz
Michael Freissmuth
Johannes M Breuss
Johannes Kepler University of Linz · ATComprehensive Cancer Center Vienna · AT

Funding

Austrian Science Fund FWF P 21301Austrian Science Fund FWF P 23199Austrian Science Fund FWF W 1205
6 · The paper itself

Abstract

aimsVascular endothelial growth factor (VEGF)-initiated angiogenesis requires coordinated proteolytic degradation of extracellular matrix provided by the urokinase plasminogen activator/urokinase receptor (uPA/uPAR) system and regulation of cell migration provided by integrin-matrix interaction. In this study, we investigated the mechanisms underlying the uPAR-dependent modulation of VEGF-induced endothelial migration. METHODS AND

resultsWe used flow cytometry to quantify integrins at the cell surface. Stimulation of human and murine endothelial cells with VEGF resulted in internalization of α5β1-integrins. Micropatterning and immunocytochemistry revealed co-clustering of uPAR and α5β1-integrins and retrieval via clathrin-coated vesicles. It was also contingent on receptors of the low-density lipoprotein receptor (LDL-R) family. VEGF-induced integrin redistribution was inhibited by elimination of uPAR from the endothelial cell surface or by inhibitory peptides that block the uPAR-integrin interaction. Under these conditions, the migratory response of endothelial cells upon VEGF stimulation was impaired both in vitro and in vivo.

conclusionsThe observations indicate that uPAR is an essential component of the network through which VEGF controls endothelial cell migration. uPAR is a bottleneck through which the VEGF-induced signal must be funnelled for both focused proteolytic activity at the leading edge and for redistribution of integrins.

Indexed as

Cell MovementNeovascularization, PhysiologicAnimalsCells, CulturedClathrin-Coated VesiclesEndocytosisEndothelial CellsFlow CytometryHumansHuman Umbilical Vein Endothelial CellsImmunohistochemistryIntegrin alpha5beta1MiceMice, KnockoutProtein TransportReceptors, LDLIntegrin alpha5beta1PLAUR protein, humanPlaur protein, mouseReceptors, LDLReceptors, Urokinase Plasminogen ActivatorRecombinant ProteinsVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID22287577
PMCPMC6176909
OpenAlexW2100585067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.